McKesson EBIT 2010-2024 | MCK

McKesson annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • McKesson EBIT for the quarter ending September 30, 2024 was $0.578B, a 39.22% decline year-over-year.
  • McKesson EBIT for the twelve months ending September 30, 2024 was $3.465B, a 18.89% decline year-over-year.
  • McKesson 2024 annual EBIT was $3.909B, a 10.77% decline from 2023.
  • McKesson 2023 annual EBIT was $4.381B, a 114.97% increase from 2022.
  • McKesson 2022 annual EBIT was $2.038B, a 140.44% decline from 2021.
McKesson Annual EBIT
(Millions of US $)
2024 $3,909
2023 $4,381
2022 $2,038
2021 $-5,040
2020 $2,489
2019 $886
2018 $762
2017 $7,122
2016 $3,545
2015 $2,968
2014 $2,439
2013 $2,347
2012 $2,124
2011 $1,821
2010 $2,008
2009 $1,196
McKesson Quarterly EBIT
(Millions of US $)
2024-09-30 $578
2024-06-30 $1,029
2024-03-31 $1,216
2023-12-31 $642
2023-09-30 $951
2023-06-30 $1,100
2023-03-31 $980
2022-12-31 $1,241
2022-09-30 $1,124
2022-06-30 $1,036
2022-03-31 $633
2021-12-31 $298
2021-09-30 $539
2021-06-30 $568
2021-03-31 $1,010
2020-12-31 $-7,362
2020-09-30 $634
2020-06-30 $678
2020-03-31 $869
2019-12-31 $360
2019-09-30 $626
2019-06-30 $634
2019-03-31 $-569
2018-12-31 $683
2018-09-30 $689
2018-06-30 $83
2018-03-31 $-944
2017-12-31 $834
2017-09-30 $239
2017-06-30 $633
2017-03-31 $4,739
2016-12-31 $831
2016-09-30 $580
2016-06-30 $972
2016-03-31 $740
2015-12-31 $920
2015-09-30 $954
2015-06-30 $931
2015-03-31 $700
2014-12-31 $800
2014-09-30 $787
2014-06-30 $681
2014-03-31 $605
2013-12-31 $493
2013-09-30 $686
2013-06-30 $655
2013-03-31 $667
2012-12-31 $498
2012-09-30 $606
2012-06-30 $576
2012-03-31 $682
2011-12-31 $492
2011-09-30 $478
2011-06-30 $472
2011-03-31 $623
2010-12-31 $307
2010-09-30 $417
2010-06-30 $474
2010-03-31 $573
2009-12-31 $509
2009-09-30 $467
2009-06-30 $459
2009-03-31 $498
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.151B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36